Midazolam

also known as Midazolam Hydrochloride · Dormicum · MDZ · Versed · USL261 · MDZ-NS · MID · Midazolam Maleate · +23 more

Developed for: anxiety · epilepsy · delirium · respiratory failure · major depressive disorder · depressive disorder · infectious disease with sepsis · acute respiratory distress syndrome
+40 more
· anxiety disorder · cataract · cirrhosis of liver · cognitive disorder · dental caries · chronic pain syndrome · gastroesophageal reflux disease · nervous system disorder · nicotine dependence · traumatic brain injury · acute lung injury · acute myocardial infarction · bipolar disorder · cardiac valvular defect · catatonia · coronary artery disorder · epilepsy syndrome · neuropathy, painful · pulmonary edema · sleep disorder · substance withdrawal syndrome · abscess · acute respiratory failure · bipolar depression · cardiogenic shock · childhood malignant neoplasm · cocaine dependence · critical illness polyneuropathy · drug-induced akathisia · encephalopathy, acute, infection-induced · epilepsy with generalized tonic-clonic seizures · hypertensive disorder · kidney failure · myocardial infarction · paroxysmal extreme pain disorder · post-traumatic stress disorder · preeclampsia/eclampsia 3 · pregnancy disorder with abortive outcome · subacute delirium · substance abuse
Investigated by: Pfizer · Boehringer Ingelheim · Eli Lilly and Company · AstraZeneca · GlaxoSmithKline · Bristol-Myers Squibb
+456 more
· Janssen Research & Development, LLC · Hoffmann-La Roche · Bayer · Novartis Pharmaceuticals · ViiV Healthcare · Merck Sharp & Dohme LLC · Idorsia Pharmaceuticals Ltd. · Seoul National University Hospital · AbbVie · Amgen · Assistance Publique - Hôpitaux de Paris · National Center for Complementary and Integrative Health (NCCIH) · Takeda · Vertex Pharmaceuticals Incorporated · Ain Shams University · Assiut University · Benha University · Eisai Inc. · Enanta Pharmaceuticals, Inc · Eye & ENT Hospital of Fudan University · Jiangsu HengRui Medicine Co., Ltd. · Johns Hopkins University · Lakefront Biotherapeutics NV · Parexel · Radboud University Medical Center · Sanofi · Shionogi · Tanta University · UCB Biopharma S.P.R.L. · University Hospital, Basel, Switzerland · University of Washington · Washington State University · Beijing Tiantan Hospital · Blueprint Medicines Corporation · Brigham and Women's Hospital · Cairo University · Celgene Corporation · Columbia University · Daiichi Sankyo · Genentech, Inc. · LEO Pharma · Loxo Oncology, Inc. · Shire · University of Wisconsin, Madison · West China Hospital · Yonsei University · Achillion, a wholly owned subsidiary of Alexion · Alexion Pharmaceuticals, Inc. · Astellas Pharma Europe B.V. · Astellas Pharma Global Development, Inc. · Astellas Pharma Inc · Biogen · Celerion · Changhai Hospital · Chinese Medical Association · Chinese University of Hong Kong · Chong Kun Dang Pharmaceutical · Covance · DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company · Emalex Biosciences Inc. · Emergency Medicine Foundation · Erasme University Hospital · European and Developing Countries Clinical Trials Partnership (EDCTP) · Federal University of Goiás · German Federal Ministry of Education and Research · Global Alliance for TB Drug Development · Guangdong Raynovent Biotech Co., Ltd · H. Lundbeck A/S · Hammersmith Medicines Research · Harmony Biosciences Management, Inc. · Jemincare · Jiangsu Hansoh Pharmaceutical Co., Ltd. · Jiangsu Simcere Pharmaceutical Co., Ltd. · Jules Desmeules · all 462 on the full record

Regulatory milestones approvals, filings & regulatory actions · 5 recorded

Milestone	Jurisdiction	Brand	Indication	Date	Sentence it was read from
Approved	EU (EMA)	Buccolam	—	2011-09-04	europa.eu ↗
Label expansions (3)	US (FDA)	VERSED	—	1994-04-26 – 1997-03-18	fda.gov ↗
Approved	US (FDA)	VERSED	—	1985-12-20	fda.gov ↗

Trials 648 · started per year

today

US approved 1985

EU approved 2011

1983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049205020512052205320542055205620572058205920602061206220632064206520662067206820692070207120722073207420752076207720782079208020812082208320842085208620872088208920902091209220932094209520962097209820992100210121022103

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 013 trials
Phase 0	NCT05264077	Nov 2024 → Jun 2025 overdue	—	Sheikh Zayed Medical College	Not yet recruiting	No outcome recorded
Phase 0	NCT06693960	Sep 2024 → Dec 2026 expected	—	Washington State University	Recruiting	No outcome recorded
Phase 0	NCT06215768	Jan → Sep 2024	delirium	Esraa Abdel Azez Soltan Mohamed Zayed	Unknown	No outcome recorded
Phase 0	NCT05891119	Jun 2023 → Aug 2024	atopic eczema	Amgen	Completed	No outcome recorded
Phase 0	NCT05505630	Jan 2023 → Dec 2025	nicotine dependence	Wake Forest University Health Sciences	Completed	No outcome recorded
Phase 0	NCT05574179	Jan → Jul 2023	—	Sheikh Zayed Medical College	Unknown	No outcome recorded
Phase 0	NCT05579509	Oct 2022 → May 2024	—	Brigham and Women's Hospital	Completed	No outcome recorded
Phase 0	NCT04807101	Apr 2021 → Jul 2023	—	Greg S Cohen MD LLC	Completed	No outcome recorded
Phase 0	NCT04718259	Jan 2020 → Feb 2021	—	Tanta University	Completed	No outcome recorded
Phase 0	NCT06271096	Nov 2019 → Nov 2022	epilepsy	Arooj Khan	Completed	No outcome recorded
Phase 0	NCT04392011	Oct 2019 → Aug 2021	—	Washington State University	Completed	No outcome recorded
Phase 0	NCT03772262	Apr → Nov 2018	—	Washington State University	Completed	No outcome recorded
Phase 0	NCT03049293	Jun 2017 → Oct 2019	—	ART Fertility Clinics LLC	Terminated	No outcome recorded Stop: Enrollment

Phase 1410 trials · 3 met primary · 1 missed
Phase 1	NCT07862621	Nov 2026 → Feb 2027 expected	—	Merck Sharp & Dohme LLC	Not yet recruiting	No outcome recorded
Phase 1	NCT07859007	Oct → Nov 2026 expected	—	Insmed Incorporated	Not yet recruiting	No outcome recorded
Phase 1	NCT07820891	Sep → Nov 2026 expected	—	BeOne Medicines	Recruiting	No outcome recorded
Phase 1	NCT07867340	Sep 2026 → Jan 2027 expected	—	Eli Lilly and Company	Not yet recruiting	No outcome recorded
Phase 1	NCT07800897	Aug 2026 → Mar 2027 expected	—	Bristol-Myers Squibb	Recruiting	No outcome recorded
Phase 1	NCT07765498	Aug 2026 → Jan 2027 expected	—	Eli Lilly and Company	Recruiting	No outcome recorded
Phase 1	NCT07710768	Jul 2026 → Apr 2027 expected	obesity disorder	Novo Nordisk A/S	Not yet recruiting	No outcome recorded
Phase 1	NCT07665723	Jun 2026 → Jul 2027 expected	ulcerative colitis	Hoffmann-La Roche	Recruiting	No outcome recorded
Phase 1	NCT07685041	Jun → Nov 2026 expected	non-small cell lung carcinoma	Jiangsu Hansoh Pharmaceutical Co., Ltd.	Not yet recruiting	No outcome recorded
Phase 1	NCT07670377	Jun → Aug 2026	Plasmodium falciparum malaria	GlaxoSmithKline	Completed	No outcome recorded
Show all 410 trials opens the full record — a long page
Phase 1/212 trials · 2 met primary
Phase 1/2	NCT05384626	Jun 2022 → Dec 2027 expected	metastatic neoplasm	Nuvalent Inc.	Recruiting	No outcome recorded
Phase 1/2	NCT04586504	Sep 2021 → May 2024	anxiety	Columbia University	Completed	No outcome recorded
Phase 1/2	NCT04141696	Jul 2021 → Mar 2024	—	National Institute of Nursing Research (NINR)	Completed	No outcome recorded
Phase 1/2	NCT03760445	Nov 2019 → Jul 2021	acute myeloid leukemia	Novartis Pharmaceuticals	Withdrawn	No outcome recorded
Phase 1/2	NCT04044001	Nov 2019 → Mar 2022	pulmonary tuberculosis	Michael Hoelscher	Completed	No outcome recorded
Phase 1/2	NCT04067336	Sep 2019 → Oct 2028 expected	mixed phenotype acute leukemia with MLL rearranged	Kura Oncology, Inc.	Active not recruiting	Met primary
Phase 1/2	NCT03813121	Jun 2019 → Aug 2021	nicotine dependence	Wake Forest University Health Sciences	Completed	No outcome recorded
Phase 1/2	NCT03600883	Aug 2018 → May 2026	—	Amgen	Completed	No outcome recorded
Phase 1/2	NCT03535168	May 2018 → Sep 2019	—	Bayer	Completed	Met primary
Phase 1/2	NCT03436485	Mar 2018 → Jul 2026 overdue	prostate cancer	Orion Corporation, Orion Pharma	Active not recruiting	No outcome recorded
Phase 1/2	NCT02014558	Oct 2013 → Aug 2017	acute myeloid leukemia	Astellas Pharma Global Development, Inc.	Completed	No outcome recorded
Phase 1/2	NCT02050893	May 2012 → Apr 2013	infectious disease with sepsis	Southeast University, China	Completed	No outcome recorded

Phase 221 trials · 1 met primary
Phase 2	NCT05945147	Jan → Apr 2099	complex regional pain syndrome	Stanford University	Withdrawn	No outcome recorded Stop: Business
Phase 2	NCT07668700	Dec 2025 → Jun 2026	—	Hameed Latif Hospital, Lahore	Completed	No outcome recorded
Phase 2	NCT07519863	Nov 2025 → Nov 2026 expected	—	Ain Shams University	Recruiting	No outcome recorded
Phase 2	NCT05057689	Sep → Oct 2025	acute stress disorder, anxiety	Nationwide Children's Hospital	Withdrawn	No outcome recorded Stop: Business
Phase 2	NCT06638710	Jul 2025 → Jun 2026 overdue	cognitive disorder	University Hospital, Grenoble	Recruiting	No outcome recorded
Phase 2	NCT06979791	Jun 2025 → May 2026	—	Cairo University	Completed	No outcome recorded
Phase 2	NCT07620912	Apr 2025 → Apr 2026	chronic obstructive pulmonary disease, respiratory failure	Al-Azhar University	Completed	No outcome recorded
Phase 2	NCT06111872	Jul 2023 → Feb 2024	bile duct cyst, cholangitis, choledocholithiasis, malignant pancreatic neoplasm	National University of Malaysia	Completed	No outcome recorded
Phase 2	NCT05378100	Jan 2023 → May 2026 overdue	myalgic encephalomeyelitis/chronic fatigue syndrome	Johns Hopkins University	Active not recruiting	No outcome recorded
Phase 2	NCT04562116	Dec 2021 → Jun 2023	atopic eczema	Galderma R&D	Completed	No outcome recorded
Phase 2	NCT03959566	May 2021 → Sep 2022	pulmonary tuberculosis	Michael Hoelscher	Completed	Met primary
Phase 2	NCT04557449	Sep 2020 → Sep 2026 overdue	breast neoplasm, liposarcoma, lung adenocarcinoma, prostate cancer	Pfizer	Active not recruiting	No outcome recorded
Phase 2	NCT02232139	Mar 2016 → Jun 2019	—	University Medicine Greifswald	Completed	No outcome recorded
Phase 2	NCT04608734	Jun 2015 → Jun 2016	—	Nourhan M.Aly	Completed	No outcome recorded
Phase 2	NCT02365597	Apr 2015 → Sep 2022 overdue	urothelial carcinoma	Janssen Research & Development, LLC	Active not recruiting	No outcome recorded
Phase 2	NCT01948908	Jun 2013 → Sep 2015	—	Columbia University	Completed	No outcome recorded
Phase 2	NCT01441505	Sep 2011 → Dec 2014	major depressive disorder	The University of New South Wales	Unknown	No outcome recorded
Phase 2	NCT00942539	Jul 2009 → Jul 2011	anxiety	Rambam Health Care Campus	Terminated	No outcome recorded
Phase 2	NCT00869440	Mar → Sep 2009	—	Paion UK Ltd.	Completed	No outcome recorded
Phase 2	NCT00176670	Jan 2004 → Apr 2006	anxiety	University of Medicine and Dentistry of New Jersey	Completed	No outcome recorded
Phase 2	NCT00248729	Oct 2002 → Nov 2005	respiratory failure	St. Luke's Hospital, Pennsylvania	Completed	No outcome recorded

Phase 2/36 trials · 1 met primary
Phase 2/3	NCT07095842	Aug 2025 → Jul 2026 overdue	epilepsy syndrome	Sohag University	Recruiting	No outcome recorded
Phase 2/3	NCT06752616	Dec 2024 → Dec 2027 expected	—	Lone Baandrup	Recruiting	No outcome recorded
Phase 2/3	NCT05883150	Nov 2022 → Aug 2023	—	Nourhan M.Aly	Completed	No outcome recorded
Phase 2/3	NCT02713191	Mar 2016 → Feb 2017	—	Post Graduate Institute of Medical Education and Research, Chandigarh	Completed	Met primary
Phase 2/3	NCT01275547	Jan → Jun 2011	spinal stenosis	University Hospital, Basel, Switzerland	Completed	No outcome recorded
Phase 2/3	NCT00125424	Jul → Sep 2005	polyp of colon	Eisai Inc.	Completed	No outcome recorded
Phase 328 trials · 1 met primary · 3 missed
Phase 3	NCT07155265	Oct 2025 → Jun 2027 expected	respiratory failure	Yancheng First People's Hospital	Not yet recruiting	No outcome recorded
Phase 3	NCT07019805	Sep 2024 → Mar 2025	acute hypotension	Indonesia University	Completed	No outcome recorded
Phase 3	NCT06383273	May → Dec 2024 overdue	cataract	Melt Pharmaceuticals	Recruiting	No outcome recorded
Phase 3	NCT05383495	Dec 2023 → Dec 2025 overdue	—	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	Recruiting	No outcome recorded
Phase 3	NCT05646862	Jun 2023 → Nov 2026 expected	breast cancer	Hoffmann-La Roche	Recruiting	No outcome recorded
Phase 3	NCT05681572	Apr 2023 → Oct 2027 expected	—	University Hospital, Montpellier	Recruiting	No outcome recorded
Phase 3	NCT05324852	Apr 2023	delirium	Assistance Publique - Hôpitaux de Paris	Terminated	No outcome recorded Stop: Business
Phase 3	NCT05121324	Aug 2022 → Jul 2026 overdue	epilepsy	Stanford University	Recruiting	No outcome recorded
Phase 3	NCT05208047	Apr 2022 → Sep 2025 overdue	gastrointestinal stromal tumor, metastatic malignant neoplasm	Cogent Biosciences, Inc.	Recruiting	No outcome recorded
Phase 3	NCT05126459	Feb 2022 → Apr 2023	anxiety, dental caries	Loma Linda University	Completed	No outcome recorded
Phase 3	NCT04571879	Aug 2021 → Dec 2023	anxiety	Hamad Medical Corporation	Unknown	No outcome recorded
Phase 3	NCT04134052	Jan → May 2021	cognitive disorder	University of Colima	Unknown	No outcome recorded
Phase 3	NCT04160611	Sep 2019 → Jun 2020	—	University Hospital Sestre Milosrdnice	Unknown	No outcome recorded
Phase 3	NCT03336450	Apr 2018 → Oct 2020	nervous system disorder	Shire	Completed	No outcome recorded
Phase 3	NCT03483350	Mar → Aug 2018	—	Assiut University	Unknown	No outcome recorded
Phase 3	NCT04276545	Jan 2018 → Mar 2020	hemorrhagic disease	Eye & ENT Hospital of Fudan University	Completed	No outcome recorded
Phase 3	NCT03336645	Oct 2017 → Aug 2019	nervous system disorder	Shire	Completed	No outcome recorded
Phase 3	NCT02374567	Jan 2015 → Jun 2017	anxiety disorder, dementia, depressive disorder, schizophrenia +1	Hannover Medical School	Terminated	No outcome recorded
Phase 3	NCT02161185	May 2014 → May 2015	epilepsy	UCB Biopharma S.P.R.L.	Terminated	No outcome recorded Stop: Enrollment
Phase 3	NCT01999777	Nov 2013 → Aug 2015	epilepsy	UCB Biopharma S.P.R.L.	Completed	Missed primary
Phase 3	NCT01529034	Jul 2012 → Apr 2017	epilepsy	UCB Biopharma S.P.R.L.	Terminated	No outcome recorded
Phase 3	NCT01462318	Nov 2011 → Jan 2016	relapsing-remitting multiple sclerosis	Biogen	Completed	No outcome recorded
Phase 3	NCT01390220	Jun 2011 → Mar 2017	epilepsy	UCB Biopharma S.P.R.L.	Terminated	Met primary
Phase 3	NCT00416039	Jan 2007 → Nov 2008	—	Assistance Publique - Hôpitaux de Paris	Completed	Missed primary
Phase 3	NCT01731184	Nov 2006 → Sep 2009	—	Centre Hospitalier de Cornouaille	Completed	Missed primary
Phase 3	NCT00261599	Mar → Oct 2006	—	Eisai Inc.	Completed	No outcome recorded
Phase 3	NCT01874717	Jun 2005 → Aug 2007	—	University Hospital, Clermont-Ferrand	Completed	No outcome recorded
Phase 3	NCT00221520	Feb 2003 → Jan 2007	respiratory failure	University Hospital, Geneva	Unknown	No outcome recorded

Phase 477 trials · 5 met primary · 5 missed
Phase 4	NCT07855523	Nov 2026 → Nov 2027 expected	—	Assiut University	Not yet recruiting	No outcome recorded
Phase 4	NCT07704658	Jun 2026 → Jul 2027 expected	non-small cell lung carcinoma, thyroid cancer	Rigel Pharmaceuticals	Recruiting	No outcome recorded
Phase 4	NCT07556523	Mar 2026 → Apr 2028 expected	aortic valve stenosis	David Lyubashevsky	Recruiting	No outcome recorded
Phase 4	NCT07300826	Jan 2026 → Feb 2027 expected	—	Assiut University	Not yet recruiting	No outcome recorded
Phase 4	NCT06763705	Jun → Dec 2025	—	Qassim Health Cluster	Completed	No outcome recorded
Phase 4	NCT07190612	Dec 2024 → Apr 2026	—	Ain Shams University	Completed	No outcome recorded
Phase 4	NCT06887712	Apr → Dec 2024	—	Hanoi Medical University	Completed	No outcome recorded
Phase 4	NCT05934669	Nov 2023 → May 2025	anxiety	University of Oklahoma	Unknown	No outcome recorded
Phase 4	NCT06273215	Mar 2023 → Dec 2025	diabetes mellitus	Peking University Third Hospital	Unknown	No outcome recorded
Phase 4	NCT05874245	Mar 2023 → Mar 2024	—	Menoufia University	Unknown	No outcome recorded
Phase 4	NCT05707234	Feb → Aug 2023	anxiety disorder, osteoarthritis, knee	University of Liege	Completed	No outcome recorded
Phase 4	NCT05469204	Nov 2022 → Jul 2025	—	University of Washington	Completed	No outcome recorded
Phase 4	NCT05658692	Oct 2022 → Oct 2023	acute respiratory distress syndrome	Second Affiliated Hospital, School of Medicine, Zhejiang University	Unknown	No outcome recorded
Phase 4	NCT05553678	Sep 2022 → Sep 2023	—	Seoul National University Hospital	Unknown	No outcome recorded
Phase 4	NCT05747768	Jul 2022 → Jun 2024	chronic kidney disease	Peking University Third Hospital	Unknown	No outcome recorded
Phase 4	NCT05369819	May 2022 → Jan 2024	—	Karaman Training and Research Hospital	Completed	No outcome recorded
Phase 4	NCT05368441	May → Dec 2022	—	Karaman Training and Research Hospital	Completed	Met primary
Phase 4	NCT05994547	Apr 2022 → Jun 2023	—	Chungbuk National University Hospital	Completed	Met primary
Phase 4	NCT05045378	Mar 2022 → Nov 2024	major depressive disorder	Taipei Veterans General Hospital, Taiwan	Completed	No outcome recorded
Phase 4	NCT04885075	May → Nov 2021	epilepsy	Shaheed Zulfiqar Ali Bhutto Medical University	Unknown	No outcome recorded
Phase 4	NCT06315634	Mar 2021 → Mar 2022	—	National Cancer Institute, Egypt	Completed	No outcome recorded
Phase 4	NCT04119180	Jan 2020 → Feb 2025 overdue	dental caries	Federal University of Goiás	Recruiting	No outcome recorded
Phase 4	NCT04174872	Dec 2019 → Feb 2021	—	Cairo University	Completed	No outcome recorded
Phase 4	NCT03933007	Sep → Oct 2019	gout	Assistance Publique - Hôpitaux de Paris	Terminated	No outcome recorded
Phase 4	NCT03809442	Jun 2019 → Aug 2023	—	Aga Khan University	Completed	No outcome recorded
Phase 4	NCT03534895	May 2019 → May 2020	neuropathy, painful	University of Porto	Unknown	No outcome recorded
Phase 4	NCT05670509	Jan 2019 → Jul 2022	epilepsy	Ain Shams University	Completed	No outcome recorded
Phase 4	NCT03394430	Oct → Dec 2018	—	Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University	Unknown	No outcome recorded
Phase 4	NCT03960671	Aug 2018 → Dec 2022	—	Wei Zhao	Unknown	No outcome recorded
Phase 4	NCT04248335	Jul 2018 → Dec 2024	gastroesophageal reflux disease, metabolic dysfunction-associated steatotic liver disease	Children's Mercy Hospital Kansas City	Completed	No outcome recorded
Phase 4	NCT03246724	Oct 2017 → Nov 2019	—	Boston Medical Center	Completed	No outcome recorded
Phase 4	NCT03052660	Oct 2017 → Jun 2019	—	RWTH Aachen University	Completed	Missed primary
Phase 4	NCT03204578	Aug → Sep 2017	—	University Hospital, Basel, Switzerland	Completed	No outcome recorded
Phase 4	NCT03284307	Aug 2017 → Mar 2020	—	University of Wisconsin, Madison	Completed	Missed primary
Phase 4	NCT02856698	Apr 2017 → Dec 2020	pulmonary edema	Alberto Dominguez-Rodriguez	Terminated	No outcome recorded
Phase 4	NCT02009306	Jan 2017 → Feb 2018	—	Gloucestershire Hospitals NHS Foundation Trust	Completed	No outcome recorded
Phase 4	NCT03029676	Jan → Dec 2017	urinary bladder neoplasm	Medical University of Warsaw	Unknown	No outcome recorded
Phase 4	NCT02985697	Jan 2017 → Jan 2018	—	Bon Secours Pediatric Dental Associates	Unknown	No outcome recorded
Phase 4	NCT02760615	Nov 2016 → Aug 2020	Crohn disease, ulcerative colitis	Takeda	Withdrawn	No outcome recorded Stop: Enrollment
Phase 4	NCT03551067	Aug 2016 → Dec 2017	adenoid hypertrophy	Suez Canal University	Completed	No outcome recorded
Phase 4	NCT02909465	Jul 2016 → Apr 2017	—	Tehran University of Medical Sciences	Completed	Met primary
Phase 4	NCT02528513	Dec 2015 → Dec 2016	delirium	West China Hospital	Unknown	No outcome recorded
Phase 4	NCT02629146	Dec 2015 → Mar 2016	—	Wilhelminenspital Vienna	Completed	No outcome recorded
Phase 4	NCT02579928	Oct 2015 → Sep 2018	anxiety disorder, major depressive disorder	Yale University	Completed	No outcome recorded
Phase 4	NCT02634021	Jul 2015 → Jul 2018	osteoarthritis, knee	Konkuk University Medical Center	Withdrawn	No outcome recorded
Phase 4	NCT02447289	May 2015 → Oct 2016	dental caries	Federal University of Goiás	Completed	Missed primary
Phase 4	NCT02475824	May 2015 → Nov 2016	—	Dankook University	Completed	No outcome recorded
Phase 4	NCT02486328	May → Jun 2015	cognitive disorder, digestive system disorder	Ufuk University	Completed	Met primary
Phase 4	NCT02291666	Apr 2015 → Jul 2019	type 2 diabetes mellitus	University of Montreal Hospital Centre (CHUM)	Completed	No outcome recorded
Phase 4	NCT02296073	Dec 2014	—	Anhui Provincial Children's Hospital	Unknown	No outcome recorded
Phase 4	NCT03791424	Oct 2014 → Jun 2015	—	Charles University, Czech Republic	Completed	No outcome recorded
Phase 4	NCT02233972	Aug → Oct 2014	—	Jiangsu Kanion Pharmaceutical Co., Ltd	Completed	No outcome recorded
Phase 4	NCT02122055	Jun 2014 → Apr 2015	—	Tianjin Third Central Hospital	Unknown	No outcome recorded
Phase 4	NCT02168439	Jun 2014 → Apr 2015	anxiety	University of Pittsburgh	Completed	No outcome recorded
Phase 4	NCT02135055	May 2014 → Mar 2015	immune system disorder, infectious disease with sepsis	Xiangya Hospital of Central South University	Unknown	No outcome recorded
Phase 4	NCT02142595	May → Dec 2014	—	China Medical University, China	Completed	No outcome recorded
Phase 4	NCT02123589	Apr 2014 → May 2015	substance withdrawal syndrome	West China Hospital	Unknown	No outcome recorded
Phase 4	NCT02166853	Apr 2014 → Feb 2016	acute respiratory distress syndrome	University Hospital, Clermont-Ferrand	Completed	Met primary
Phase 4	NCT02080169	Feb → Dec 2014	delirium	Qilu Hospital of Shandong University	Unknown	No outcome recorded
Phase 4	NCT01993459	Feb 2014 → Oct 2015	anxiety, depressive disorder	Erasmus Medical Center	Completed	Missed primary
Phase 4	NCT02078336	Dec 2013 → Jul 2025 overdue	—	Universitaire Ziekenhuizen KU Leuven	Active not recruiting	No outcome recorded
Phase 4	NCT02937506	Nov 2013 → Mar 2016	colon carcinoma, irritable bowel syndrome, polyp	Mount Carmel Health System	Completed	No outcome recorded
Phase 4	NCT02071407	Oct 2013 → Mar 2015	traumatic brain injury	Subei People's Hospital of Jiangsu Province	Unknown	No outcome recorded
Phase 4	NCT02027311	Apr → Aug 2013	cholangiocarcinoma, choledocholithiasis, malignant pancreatic neoplasm, pancreatitis	Cheju Halla General Hospital	Completed	Missed primary
Phase 4	NCT01766050	Jan → Apr 2013	transplant rejection	Bristol-Myers Squibb	Completed	No outcome recorded
Phase 4	NCT01519726	Dec 2011 → Dec 2013	morbid obesity	St. Antonius Hospital	Completed	No outcome recorded
Phase 4	NCT01375634	May 2011 → Apr 2013	—	University of Vermont	Completed	No outcome recorded
Phase 4	NCT01321047	Apr → Sep 2011	—	Soon Chun Hyang University	Unknown	No outcome recorded
Phase 4	NCT00952653	Jun → Aug 2010	major depressive disorder	Pfizer	Completed	No outcome recorded
Phase 4	NCT00947791	Jul → Oct 2009	bipolar disorder	Icahn School of Medicine at Mount Sinai	Terminated	No outcome recorded
Phase 4	NCT00871039	Mar 2009	alcohol-related disorders	Virginia Commonwealth University	Withdrawn	No outcome recorded
Phase 4	NCT00577200	Jan 2008 → Nov 2026 expected	—	Rush University Medical Center	Active not recruiting	No outcome recorded
Phase 4	NCT00158873	Sep 2004 → ?	—	GlaxoSmithKline	Completed	No outcome recorded
Phase 4	NCT00596414	May 2003 → Oct 2005	anxiety, cirrhosis of liver, hepatitis	Erasme University Hospital	Completed	No outcome recorded
Phase 4	NCT00050180	Nov 2002 → Aug 2007	HIV infectious disease	National Institutes of Health Clinical Center (CC)	Completed	No outcome recorded
Phase 4	NCT00188227	Sep 2001 → Nov 2003	—	Technical University Dresden	Completed	No outcome recorded
Phase 4	NCT00440960	—	lung cancer	Hospital Pompeia	Completed	No outcome recorded

Phase not applicable81 trials · 2 met primary · 4 missed
—	NCT07622641	Aug 2026 → Aug 2027 expected	adenoid hypertrophy	Erzurum City Hospital	Not yet recruiting	No outcome recorded
—	NCT07678216	Jul 2026 → Jun 2028 expected	traumatic brain injury	Aswan University	Not yet recruiting	No outcome recorded
—	NCT07699523	Jun 2026 → Jun 2027 expected	electroencephalographic peculiarity: fronto-precentral beta wave groups	China-Japan Friendship Hospital	Not yet recruiting	No outcome recorded
—	NCT07498387	Jan → Aug 2026 overdue	autism spectrum disorder, catatonia	Tanta University	Active not recruiting	No outcome recorded
—	NCT07347886	Jan → Jul 2026 overdue	cataract	Istanbul University - Cerrahpasa	Not yet recruiting	No outcome recorded
—	NCT07198412	Oct 2025 → Apr 2026 overdue	chronic pain syndrome	Benha University	Recruiting	No outcome recorded
—	NCT07166666	Sep 2025 → Sep 2026 overdue	—	Oman Medical Speciality Board	Not yet recruiting	No outcome recorded
—	NCT07392983	Jul → Dec 2025	—	Muhammad Aamir Latif	Completed	No outcome recorded
—	NCT06549426	Apr 2025 → Dec 2029 expected	epilepsy	University of Twente	Recruiting	No outcome recorded
—	NCT07564037	Nov 2024 → Nov 2025	—	Tanta University	Completed	No outcome recorded
—	NCT07580768	Nov 2024 → Oct 2025	—	Tanta University	Completed	No outcome recorded
—	NCT06407518	Jul 2024 → Oct 2025 overdue	anxiety, sleep disorder	Sixth Affiliated Hospital, Sun Yat-sen University	Recruiting	No outcome recorded
—	NCT06373627	May 2024 → May 2025	congenital heart disease	Fondation Hôpital Saint-Joseph	Unknown	No outcome recorded
—	NCT06464263	Feb 2024 → Feb 2026	cardiac valvular defect	Egymedicalpedia	Unknown	No outcome recorded
—	NCT06203405	Dec 2023 → Mar 2026 overdue	acute lung injury, adult acute respiratory distress syndrome	Siriraj Hospital	Recruiting	No outcome recorded
—	NCT05741385	Oct 2023 → Aug 2024	cirrhosis of liver	Boehringer Ingelheim	Completed	No outcome recorded
—	NCT06018207	Sep → Oct 2023	—	Sixth Affiliated Hospital, Sun Yat-sen University	Completed	No outcome recorded
—	NCT05863455	May 2023 → Oct 2024	—	Affiliated Hospital of Jiaxing University	Completed	Met primary
—	NCT06056349	May 2023 → Dec 2024	epilepsy	El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez	Unknown	No outcome recorded
—	NCT06389318	Mar 2023 → Mar 2024	hernia, double inguinal	Benha University	Completed	No outcome recorded
—	NCT07072117	Feb → Aug 2023	—	Zagazig University	Completed	No outcome recorded
—	NCT05398757	Jul 2022 → Mar 2024	—	Osijek University Hospital	Withdrawn	No outcome recorded Stop: Enrollment
—	NCT04887285	Mar 2022 → Aug 2023	radiculopathy	Johns Hopkins University	Completed	No outcome recorded
—	NCT05057767	Sep 2021 → Jun 2022	—	Benha University	Completed	No outcome recorded
—	NCT04932083	Jun 2021 → Jan 2022	—	Benha University	Completed	No outcome recorded
—	NCT05518799	Apr 2021 → Dec 2022	prostate cancer	The Netherlands Cancer Institute	Completed	No outcome recorded
—	NCT07021521	Apr 2021 → Apr 2023	preeclampsia	Zhuji People's Hospital of Zhejiang Province	Completed	No outcome recorded
—	NCT04266340	Dec 2020 → Nov 2021	—	Eye & ENT Hospital of Fudan University	Completed	No outcome recorded
—	NCT03984240	Nov 2020 → Jul 2023	brain glioma	Beijing Tiantan Hospital	Completed	No outcome recorded
—	NCT04601350	Nov 2020 → May 2022	—	Yangzhou University	Completed	No outcome recorded
—	NCT05417529	Mar 2020	oral cavity carcinoma	Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari	Completed	No outcome recorded
—	NCT04284150	Feb → Jun 2020	—	Lianyungang Hospital Affiliated Bengbu Medical College	Unknown	No outcome recorded
—	NCT04018703	Nov 2019 → Jul 2021	—	Eye & ENT Hospital of Fudan University	Unknown	No outcome recorded
—	NCT04232150	Jun → Oct 2019	—	University of Jordan	Completed	No outcome recorded
—	NCT03918889	May 2019 → Dec 2020	—	Eye & ENT Hospital of Fudan University	Unknown	Met primary
—	NCT03813043	Feb → Nov 2019	gastroesophageal reflux disease	King Fahad Specialist Hospital Dammam	Unknown	No outcome recorded
—	NCT03830086	Feb → Apr 2019	—	IRCCS Azienda Ospedaliero-Universitaria di Bologna	Completed	No outcome recorded
—	NCT05290324	Feb 2019 → Feb 2020	coronary artery disorder	Chaudhry Pervaiz Elahi Institute of Cardiology	Completed	No outcome recorded
—	NCT03778723	Dec 2018 → Dec 2019	brain aneurysm	Mansoura University	Completed	No outcome recorded
—	NCT03738137	Aug 2018 → Jan 2019	—	Guangzhou Institute of Respiratory Disease	Completed	No outcome recorded
—	NCT03388957	Jul 2018 → Oct 2019	—	Damascus University	Completed	No outcome recorded
—	NCT03603119	May 2018 → Nov 2019	—	Institute of Liver and Biliary Sciences, India	Completed	No outcome recorded
—	NCT03337945	Apr 2018 → Jun 2021	cirrhosis of liver	University Hospital, Basel, Switzerland	Completed	No outcome recorded
—	NCT03401736	Mar 2018 → Oct 2020	—	Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University	Withdrawn	No outcome recorded
—	NCT03406533	Feb → Mar 2018	—	Changhai Hospital	Terminated	No outcome recorded
—	NCT03293342	Sep 2017 → Nov 2020	—	University of Oslo	Unknown	No outcome recorded
—	NCT03653520	Jun → Nov 2017	cataract	Avanti Anesthesia	Completed	No outcome recorded
—	NCT03343873	Apr 2017 → Dec 2025 overdue	—	Beijing Tiantan Hospital	Recruiting	No outcome recorded
—	NCT02966743	Nov 2016 → Oct 2017	brain hypoxia - ischemia	Gachon University Gil Medical Center	Withdrawn	No outcome recorded
—	NCT03678532	Jul 2016 → Nov 2017	—	Assiut University	Completed	No outcome recorded
—	NCT02590185	Dec 2015 → Dec 2019	major depressive disorder	Assistance Publique - Hôpitaux de Paris	Unknown	No outcome recorded
—	NCT02789527	Nov 2015 → Apr 2017	—	Estella S. Poloni	Completed	No outcome recorded
—	NCT02502877	Jul 2015 → Mar 2016	—	Hospital da Luz, Portugal	Completed	No outcome recorded
—	NCT03237806	May 2015 → Jan 2018	acute respiratory distress syndrome	Southeast University, China	Completed	No outcome recorded
—	NCT02439164	May 2015 → Mar 2017	glioma	Beijing Tiantan Hospital	Completed	No outcome recorded
—	NCT02438072	Dec 2014 → Dec 2015	depressive disorder	University Hospital, Geneva	Unknown	No outcome recorded
—	NCT02419547	Jul 2014 → Apr 2015	ventricular tachycardia	Brigham and Women's Hospital	Completed	No outcome recorded
—	NCT02056236	Apr 2014 → Apr 2021	cardiac arrest	University of Twente	Completed	Missed primary
—	NCT02134327	Apr 2014	delirium	Nemours Children's Clinic	Withdrawn	No outcome recorded
—	NCT01979653	Nov 2013	—	Severance Hospital	Withdrawn	No outcome recorded
—	NCT01945476	Sep 2013 → Aug 2014	breast cancer	Yonsei University	Completed	No outcome recorded
—	NCT02174588	Jan 2013 → Feb 2015	—	Yonsei University	Completed	No outcome recorded
—	NCT01680471	Jul → Nov 2012	delirium	Korea University Anam Hospital	Completed	No outcome recorded
—	NCT03563287	Jan 2012 → Dec 2014	morbid obesity	University of Eastern Finland	Completed	No outcome recorded
—	NCT01361217	Sep 2011 → Jun 2012	—	University of Washington	Completed	Missed primary
—	NCT01618396	Mar → Aug 2011	infectious disease with sepsis	Casa de Saúde São José	Completed	No outcome recorded
—	NCT01472835	Mar 2011 → Feb 2013	arthritis, sacroiliac	Johns Hopkins University	Completed	No outcome recorded
—	NCT01315158	Jan 2011 → Jul 2014	obesity disorder, obstructive sleep apnea syndrome	Washington University School of Medicine	Terminated	No outcome recorded
—	NCT01333059	Sep 2010 → Oct 2012	respiratory failure	Javier Gelvez, MD	Terminated	No outcome recorded Stop: Enrollment
—	NCT01173640	Jul 2010 → Feb 2011	—	University of Washington	Completed	No outcome recorded
—	NCT01147146	Jun → Dec 2010	—	Yonsei University	Completed	No outcome recorded
—	NCT01053871	Jan → May 2010	functional gastric disease, gastritis	Shandong University	Completed	No outcome recorded
—	NCT00783731	Oct 2008 → Oct 2010	—	Seoul National University Hospital	Completed	No outcome recorded
—	NCT00441792	Oct 2007 → Dec 2010	infectious disease with sepsis	Advocate Hospital System	Completed	Missed primary
—	NCT00675909	Nov 2006 → Dec 2009	anxiety	Seattle Children's Hospital	Completed	Mixed
—	NCT00894465	Aug 2006 → Jun 2009	vesicoureteral reflux	Washington University School of Medicine	Terminated	No outcome recorded
—	NCT00337792	Jun 2006 → Jul 2007	—	Planned Parenthood League of Massachusetts	Terminated	Missed primary Stop: Enrollment
—	NCT01491009	May 2006 → Feb 2007	—	Gazi University	Completed	No outcome recorded
—	NCT00563069	Sep 2005 → Dec 2006	—	Hospital Authority, Hong Kong	Unknown	No outcome recorded
—	NCT00261261	Jan 2001 → Dec 2004	anxiety	Yale University	Completed	No outcome recorded
—	NCT00004424	Jul 1996 → Mar 2000	respiratory system disorder	FDA Office of Orphan Products Development	Completed	No outcome recorded

Comparator or background therapy559 trials
Phase 0	NCT07502651 Comparator	May 2025 → Mar 2027 expected	—	Postgraduate Institute of Dental Sciences Rohtak	Enrolling by invitation	No outcome recorded
Phase 0	NCT07040163 Background	Mar 2025 → Feb 2026 overdue	—	CAMC Health System	Active not recruiting	No outcome recorded
Phase 0	NCT06368219 Comparator	Apr → Sep 2024	—	Alexandria University	Unknown	No outcome recorded
Phase 0	NCT05344495 Comparator	Jan → Jul 2022	neuropathy, painful	Minia University	Unknown	No outcome recorded
Phase 0	NCT04326738 Comparator	Jan → Apr 2020	—	Yangzhou University	Completed	No outcome recorded
Show all 559 trials opens the full record — a long page

Press releases naming this drug 6 releases

Date	Issuer	Release
2022-12-21	Harrow Inc	Melt Pharmaceuticals’ MELT-300 (Midazolam 3mg and Ketamine 50mg Sublingual Tablet) Achieves Primary Sedation Endpoint in Phase 2 Pivotal Efficacy and Safety Study harrow.com ↗
2022-11-02	Crossject	Clinical demonstration of ZENEO® efficiency for intramuscular injection of midazolam crossject.com ↗
2022-06-01	Crossject	First injections of ZENEO® Midazolam for the clinical bioequivalence study crossject.com ↗
2018-04-10	Harrow Inc	Imprimis Pharmaceuticals to feature its patent-pending cyclosporine/chondroitin sulfate and patented non-opioid MKO Melt® (midazolam/ketamine/ondansetron) formulations at the upcoming Cataract & Refractive Surgery Medical Meeting harrow.com ↗
2013-12-20	Astellas Pharma Inc	Approval of Additional Indication for Hypnosedative, Dormicum® in Japan astellas.com ↗
2008-11-13	Wockhardt	Wockhardt launches Midazolam in the US market wockhardt.com ↗

Evidence & citations 35 cited values

Every value below carries the sentence it was read from. 1,214 sources stand behind the page.

Field	Value	Cited text
Known as	Midazolam	“Continuous infusion of fentanyl and midazolam is started and titrated to target pain and RASS score: Fentanyl started at 25 mcg/hr titrated by 25 mcg/hr every 30 minutes to...” NCT02219659 ↗ 1191 “We administered the Basel phenotyping cocktail (caffeine, efavirenz, flurbiprofen, omeprazole, metoprolol, midazolam) to patients with liver cirrhosis (n = 16 Child A, n = 15...” PMID 37328712 ↗ Jun 2023 “The intervention is a standardized seizure protocol for paramedics that prioritizes administration of only intramuscular (IM) or intranasal (IN) midazolam, up to 2 doses given...” NCT05121324 ↗ “Nirogacestat 100 mg BID will be administered orally from Day 1 through Day 17 and an oral dose of CYP cocktail (CYP2B6 [bupropion 20 mg], CYP2C8 [repaglinide 0.05 mg], CYP2C9...” NCT07259330 ↗ “Ten healthy Caucasian subjects were orally dosed with the CIME combination (caffeine-CYP1A2, repaglinide-CYP2C8, tolbutamide-CYP2C9, omeprazole-CYP2C19,...” PMID 25465228 ↗ Dec 2014 “Two equally loaded capsules containing: Melatonin (2.0 mg) Nicotine (1.0 mg) Bupropion (37.5 mg) Repaglinide (0.25 mg) Losartan (12.5 mg) Omeprazole (10 mg) Chlorzoxazone...” NCT03563287 ↗ “In this DDI part, each subject (n=14) will be administered midazolam (2 mg suspension) and bupropion (150 mg, tablet) together on Day 1, followed by a 7-day washout, followed...” NCT03199339 ↗ “A CYP probe cocktail composed of approved, commercially available drugs (caffeine, flurbiprofen, omeprazole, and midazolam) will be administered concomitantly as a single-dose...” NCT07426042 ↗ “Ten volunteers received an oral cocktail capsule containing low doses of the probes bupropion (CYP2B6), flurbiprofen (CYP2C9), omeprazole (CYP2C19), dextromethorphan (CYP2D6),...” PMID 24722393 ↗ Apr 2014 “The BTZ-043 groups also received oral dolutegravir (a third of participants) or a probe drug cocktail (caffeine [probe for CYP1A2], tolbutamide [CYP2C9], dextromethorphan...” PMID 39793592 ↗ Jan 2025 “The patient will be sedated with a combination of midazolam, fentanyl administered intravenously in small boluses until the desired level of sedation is achieved as expressed...” NCT03546088 ↗ Show 1,181 more sources
Known as	Dormicum	“with midazolam in a dose of 0.05mg/kg up to 0.2 mg/kg (Dormicum; Roche; USA; ampoule containing 15 mg/3 ml mixed in sugar-free apple juice limiting the total volume mixed with...” NCT03078946 ↗ 6 “Midazolam (Dormicum®; Roche; Vienna, Austria) will be applied intravenously as active placebo at a dose of 15 µg kg-1 min-1 over 5 minutes to mimic typical central nervous side...” NCT00886106 ↗ “Midazolam (Dormicum®; Roche; Vienna, Austria) will be applied iv as active placebo at a dose of 7.5 µg.kg-1.min-1 over 10 minutes to mimic typical central nervous side effects...” NCT00789386 ↗ “Midazolam will be administered as 5 milliliter (mL) of an intravenous solution for oral application (5 mg/5 mL, Dormicum).” NCT00511654 ↗ “Ketalar (Ketamin, Pfizer) and Dormicum (Midazolam, Roche)” NCT02732132 ↗ “2 ml of DORMICUM® Midazolam Hydrochloride (15 mg/3 mL)” NCT05026567 ↗ NCT02016976 ↗
Known as	Hypnovel	“Arm 1 : Hypnovel® (midazolam)” NCT02192710 ↗
Known as	IN Midazolam	“IN Midazolam” NCT04571879 ↗
Known as	MDZ	“Our aim was to compare the effects of midazolam (0.3 mg kg-1: MDZ) for premedication with age-appropriate tablet game apps (TAB) on children anxiety during and after ambulatory surgery.” PMID 28100529 ↗ Feb 2017 6 “Patients in one of the groups (called MDZ) were initially sedated with a 0.05mg/Kg bolus dose of Midazolam.” NCT02878837 ↗ “OBJECTIVE: We compared DEX with midazolam (MDZ) when used as a sedative during EBUS-TBNA.” PMID 33122573 ↗ May 2021 “Participants will be administered Midazolam (MDZ) in the presence or absence of VX-407.” NCT06345755 ↗ “using single-dose midazolam (MDZ)” NCT01162486 ↗ “Midazolam group (MDZ)” NCT03827408 ↗ “Midazolam (MDZ)” NCT07670377 ↗
Known as	MDZ-NS	“Midazolam nasal spray (MDZ-NS) is indicated for acute treatment of intermittent, stereotypic episodes of frequent seizure activity” PMID 33140403 ↗ Nov 2020 1 “a novel formulation of midazolam administered as a single-dose nasal spray (MDZ-NS)” PMID 31353457 ↗ Jul 2019
Known as	MHOS/SHP615	“A Phase 3, Multicenter, Open-label Extension Study of Buccally Administered MHOS/SHP615 in Pediatric Patients With Status Epilepticus (Convulsive) in Community Settings” NCT03336450 ↗
Known as	MID	“The purpose of this study was to compare the perioperative effects of the intramuscular (i.m.) alpha 2 agonist, dexmedetomidine (DEX), and midazolam (MID) premedication.” PMID 7943770 ↗ Oct 1994 1 “and midazolam (MID) 0.03 mg/kg” NCT02556606 ↗
Known as	mida	“Dexmedetomidine/remifentanil (dex/remi group) and midazolam/remifentanil (mida/remi group) were infused 7 days apart.” PMID 17056949 ↗ Nov 2006
Known as	Midazolam "Hameln" ATC-code: N05CD08	“Midazolam "Hameln" ATC-code: N05CD08” NCT01934088 ↗
Known as	Midazolam (Bukwang Pharm.Co., Ltd.)	“Midazolam (Bukwang Pharm.Co., Ltd.)” NCT01760642 ↗
Known as	Midazolam (hypnovel)	“Midazolam (hypnovel)” NCT01731184 ↗
Known as	MIDAZOLAM 15mg/3ml ATC N05CD08 MAN 65319	“MIDAZOLAM 15mg/3ml ATC N05CD08 MAN 65319” NCT02909049 ↗
Known as	Midazolam 1mg/ml Solution for Injection	“Midazolam 1mg/ml Solution for Injection” NCT01744184 ↗
Known as	Midazolam = Dormicum	“Midazolam = Dormicum” NCT01567657 ↗
Known as	Midazolam Braun	“The intravenous formulation Midazolam Braun 5 mg/ml (B. Braun Melsungen AG, Germany) diluted and mixed with orange juice for oral administration at doses of 0.3 mg/kg ,...” NCT06887712 ↗
Known as	Midazolam HCl	“Midazolam HCl Syrup 0.5mg/kg (Max: 15mg) taken 10-15 minutes prior to dental treatment.” NCT03360123 ↗
Known as	Midazolam Hydrochloride	“38 patients will receive midazolam hydrochloride, over six infusions, flexibly dosed between 0.02 mg/kg to 0.035 mg/kg.” NCT06480500 ↗ 17 “Each mL of syrup contains midazolam hydrochloride equivalent to 2 mg midazolam” NCT01873339 ↗ “Period 1 Day 1: single oral dose of 2.5 mg midazolam hydrochloride” NCT02473627 ↗ “2 ml of DORMICUM® Midazolam Hydrochloride (15 mg/3 mL)” NCT05026567 ↗ “Midazolam Hydrochloride 2Mg/mL Syrup” NCT03360123 ↗ “Drug: Midazolam Hydrochloride” NCT06496750 ↗ “Drug: Midazolam Hydrochloride” NCT03330990 ↗ “Drug: Midazolam Hydrochloride” NCT05004896 ↗ “midazolam hydrochloride syrup” NCT07372625 ↗ “Drug: Midazolam Hydrochloride” NCT02953210 ↗ “Drug: Midazolam Hydrochloride” NCT06867068 ↗ Show 7 more sources
Known as	Midazolam Maleate	“SHR0302 Tablets + probe drugs (Midazolam Maleate Tablets + Warfarin Sodium Tablets+ Omeprazole Enteric Capsules+ Repaglinide Tablets) + Vitamin K1 Tablets” NCT05392127 ↗ 1 NCT06610890 ↗
Known as	Midazolam Mylan	“Midazolam Mylan 5 mg/ml solution for injection 15mg Oral use Single dose 45 minutes before dental treatment” NCT02078336 ↗
Known as	Midazolam oral solution	“Drug: Midazolam oral solution” NCT06407518 ↗
Known as	Midazolam oral solution, YICHANG HUMANWELL PHARMACEUTICAL	“Midazolam oral solution, YICHANG HUMANWELL PHARMACEUTICAL” NCT06407518 ↗
Known as	Midazolam Panpharma	“1 mg of an injectable solution of Midazolam for oral administration (Midazolam Panpharma® 1mg/mL, injectable solution)” NCT02590185 ↗
Known as	Midazolam, Dormire (Cristalia Lab, Sao Paulo, Brazil)	“Midazolam, Dormire ® (Cristalia Lab, Sao Paulo, Brazil)” NCT02284204 ↗
Known as	Midazolam, Midazolam APL	“Midazolam, Midazolam APL” NCT05830799 ↗
Known as	Midazolam-ratiopharm	“Midazolam/ Midazolam-ratiopharm” NCT03353857 ↗
Known as	nMDZ	“OBJECTIVE: To compare the effectiveness of sedation by intranasal administration of midazolam (nMDZ) or ketamine (nKTM) for neonatal intubation.” PMID 28818854 ↗ Aug 2017
Known as	SHP615	ClinicalTrials.gov intervention name — accepted as the source's own label NCT03336645 ↗ 1 NCT03336450 ↗
Known as	USL261	“Midazolam Intranasal Spray (USL261)” NCT01999777 ↗ 3 “USL261 (intranasal midazolam)” NCT01529034 ↗ NCT01390220 ↗ NCT02161185 ↗
Known as	Versed	“standard therapy at this institution which consists of Versed (generic name midazolam) (5 mg) plus fentanyl (100 mcgs) as well as succinylcholine for RSI” NCT00462644 ↗ 6 “If the patient is randomized into this arm the recommended Versed and Fentanyl doses are standardized:” NCT01315158 ↗ “IV sedation with fentanyl and versed” NCT03187002 ↗ “Versed” NCT01691690 ↗ NCT04766996 ↗ NCT02419547 ↗ NCT02467023 ↗
Known as	Versed (Midazolam)	“Versed (Midazolam)” NCT01050699 ↗
Known as	Versed(Registered Trademark)	“After one dose of the sedative midazolam (Versed(Registered Trademark)): Participants will take an 8-milligram dose of midazolam syrup by mouth.” NCT00050180 ↗
Action	Inhibit	“midazolam, which is a GABA A receptor inhibitor” NCT01680471 ↗
Modality	Small molecule	“the midazolam witch is a benzodiazepine with a sedative and anxiolytic action” NCT00416039 ↗
Route	Oral	“Participants will take an 8-milligram dose of midazolam syrup by mouth.” NCT00050180 ↗